FDA Inspection 1135746 — Filipa Lynce, M.D.
The FDA completed an inspection of Filipa Lynce, M.D. on Jan 29, 2021 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 29, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Washington, DC (United States)
Additional details
Clinical Investigator (CI)